San Mateo, CA, United States of America

Osigwe Esue



 

Average Co-Inventor Count = 1.7

ph-index = 2

Forward Citations = 26(Granted Patents)


Company Filing History:


Years Active: 2012-2024

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Osigwe Esue: Innovator in Protein Stabilization

Introduction

Osigwe Esue is a notable inventor based in San Mateo, CA (US). He has made significant contributions to the field of protein stabilization, holding a total of 5 patents. His work focuses on enhancing the stability of protein formulations, which is crucial for therapeutic applications.

Latest Patents

One of his latest patents is titled "Compositions and methods for stabilizing protein-containing formulations." This invention relates to the use of certain alkylglycoside compositions to prevent aggregation and oxidation of antibodies and other proteins in therapeutically useful formulations. This innovative approach addresses a critical challenge in the pharmaceutical industry, ensuring the efficacy and safety of protein-based therapies.

Career Highlights

Osigwe Esue is currently employed at Genentech, Inc., a leading biotechnology company known for its pioneering work in the development of innovative medicines. His role at Genentech allows him to apply his expertise in protein stabilization to real-world applications, contributing to the advancement of therapeutic solutions.

Collaborations

He collaborates with various professionals in his field, including his coworker Vikas K Sharma. Their combined efforts aim to push the boundaries of protein formulation stability, enhancing the quality of therapeutic products.

Conclusion

Osigwe Esue's contributions to the field of protein stabilization through his patents and work at Genentech, Inc. highlight his importance as an inventor. His innovative approaches are paving the way for more effective therapeutic formulations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…